 |
Diabetes group urges caution on AvandiaThe latest studies on Avandia, GlaxoSmithKline's blockbuster diabetes drug, have raised enough questions about the drug's safety to worry the American Diabetes Association. Several studies now suggest the drug, which lowers blood sugar lev More… |
Saturday 23 November 2024
